|
1. Smith MH, Berman JR. What Is Rheumatoid Arthritis? JAMA. 2022;327(12):1194. doi:10.1001/jama.2022.0786 PMid:35315883 2. Jamshidi AR, Banihashemi AT, Roknsharifi S, Akhlaghi M, Salimzadeh A, Davatchi F. Estimating the prevalence and disease characteristics of rheumatoid arthritis in Tehran: A WHO-ILAR COPCORD Study. Med J Islam Repub Iran. 2014; 28:93. 3. Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother. 2009; 9(5): 745-58. doi:10.1586/ern.09.34 PMid:19402782 PMCid:PMC2696024 4. Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Thompson-Hollands J, Carl JR, et al. Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behav Ther. 2012; 43(3):666-78. doi:10.1016/j.beth.2012.01.001 PMid:22697453 PMCid:PMC3383087 5. Matcham F, Ali S, Irving K, Hotopf M, Chalder T. Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskelet Disord. 2016;17:155. doi:10.1186/s12891-016-1011-1 PMid:27068100 PMCid:PMC4827220 6. Sheehy C, Murphy E, Barry M. Depression in rheumatoid arthritis--underscoring the problem. Rheumatology (Oxford). 2006;45(11):1325-7. doi:10.1093/rheumatology/kel231 PMid:16908510 7. Leeuw M, Goossens ME, Linton SJ, Crombez G, Boersma K, Vlaeyen JW. The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. J Behav Med. 2007;30(1):77-94. doi:10.1007/s10865-006-9085-0. PMid:17180640 8. GBD 2021 Rheumatoid Arthritis Collaborators. Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(10):e594-e610. doi:10.1016/S2665-9913(23)00211-4 PMid:37795020 9. Green SB. How Many Subjects Does It Take To Do A Regression Analysis. Multivariate Behav Res. 1991; 26(3):499-510. doi:10.1207/s15327906mbr2603_7 PMid:26776715 10. Sahebi A, Asghari MJ, Salari RS. Validation of depression anxiety and stress scale (DASS-21) for an Iranian population. Iran J Developmental Psychol. 2025; 1(4): 36–54. doi:10.1016/S0037-6337(05)70907-4 11. Rahmati N, Asghari Moghadam MA, Shairi MR, Paknejad M, Rahmati Z, Ghassami M, et al. A Study of the Psychometric Properties of the Pain Catastrophizing Scale Amongst Iranian Patients with Chronic Persistent Pain. J Ilam Uni Med Sci. 2017;25(1):63-79. doi:10.29252/sjimu.25.1.63 12. Rahmati N, Asghari Moghadam M A, SHAIRI M, Paknejad M, Rahmati Z, Ghassami M, et al . A Study of the Psychometric Properties of the Pain Catastrophizing Scale Amongst Iranian Patients with Chronic Persistent Pain. J Ilam Uni Med Sci. 2017; 25(1):63-79. doi:10.29252/sjimu.25.1.63 13. Hudes K. The Tampa Scale of Kinesiophobia and neck pain, disability and range of motion: a narrative review of the literature. J Can Chiropr Assoc. 2011;55(3):222-32. 14. Jafari H, Ebrahimi I, Salavati M, Kamali M, Fata L. Psychometric Properties of iranian Version of Tampa Scale for Kinesiophobia in Low Back Pain Patients. J Rehab. 2010;11(1). 15. Thiagarajah AS, Guymer EK, Leech MT, Littlejohn GO. The relationship between fibromyalgia, stress and depression. Int J Clin Rheumatol. 2014;9(4):371-384. doi:10.2217/ijr.14.30 16. Peng B, Meng H, Guo L, Zhu J, Kong B, Qu Z, et al. Anxiety disorder and cardiovascular disease: a two-sample Mendelian randomization study. ESC Heart Fail. 2024;11(2):1174-1181. doi:10.1002/ehf2.14676 PMid:38279876 PMCid:PMC10966263 17. Getie A, Ayalneh M, Bimerew M. Global prevalence and determinant factors of pain, depression, and anxiety among cancer patients: an umbrella review of systematic reviews and meta-analyses. BMC Psychiatry. 2025;25:156. doi:10.1186/s12888-025-06599-5 PMid:39972435 PMCid:PMC11841195 18. Ionescu CE, Popescu CC, Agache M, Dinache G, Codreanu C. Depression in Rheumatoid Arthritis: Prevalence and Effects on Disease Activity. J Clin Med. 2024;13(7):2058. doi:10.3390/jcm13072058 PMid:38610822 PMCid:PMC11012436 19. Battat M, Omair N, WildAli MA, Alkaissi A, Amer R, Koni AA, et al. Assessment of depression symptoms among cancer patients: a cross-sectional study from a developing country. Sci Rep. 2024;14(1):11934. doi:10.1038/s41598-024-62935-x PMid:38789579 PMCid:PMC11126617 20. Fond G, Loundou A, Hamdani N, Boukouaci W, Dargel A, Oliveira J, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2014;264(8):651-60. doi:10.1007/s00406-014-0502-z PMid:24705634 21. Wilk M, Łosińska K, Pripp AH, Korkosz M, Haugeberg G. Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life. Rheumatol Int. 2022;42(4):669-682. doi:10.1007/s00296-021-05070-4 PMid:35098329 22. Yildirim N. Comparison of kinesiophobia in patients with rheumatoid arthritis and systemic lupus erythematosus. Eur Rev Med Pharmacol Sci. 2023; 27(23):11508-11516. doi:10.26355/eurrev_202312_34589. 23. Varallo G, Giusti EM, Scarpina F, Cattivelli R, Capodaglio P, Castelnuovo G. The Association of Kinesiophobia and Pain Catastrophizing with Pain-Related Disability and Pain Intensity in Obesity and Chronic Lower-Back Pain. Brain Sci. 2020; 11(1): 11. doi:10.3390/brainsci11010011 PMid:33374178 PMCid:PMC7823580 24. Giblon RE, Achenbach SJ, Myasoedova E, Davis JM 3rd, Kronzer VL, Bobo WV, et al. Trends in Anxiety and Depression Among Individuals With Rheumatoid Arthritis: A Population-Based Study. J Rheumatol. 2025;52(3):210-218. doi:10.3899/jrheum.2024-0165 PMid:39406405 25. Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol. 1991; 100(3):316-36. doi:10.1037//0021-843X.100.3.316 PMid:1918611 26. Picavet HSJ, Vlaeyen JWS, Schouten JSAG. Pain Catastrophizing and Kinesiophobia: Predictors of Chronic Low Back Pain. Am J Epidemiol. 2002; 156(11): 1028-1034. doi:10.1093/aje/kwf136 PMid:12446259 27. Buer N, Linton SJ. Fear-avoidance beliefs and catastrophizing: occurrence and risk factor in back pain and ADL in the general population. Pain. 2002; 99(3):485-491. doi:10.1016/S0304-3959(02)00265-8 PMid:12406524 28. Pereira MG, Carvalho C, Costa ECV, Leite Â, Almeida V. Quality of life in chronic pain patients: Illness- and wellness-focused coping as moderators. Psych J. 2021;10(2):283-294. doi:10.1002/pchj.410. PMid:33378796
|